SEC Filings for ADMA Biologics Inc (ADMA)

$ 3.29   0.43 (+15.03%) Volume: 10.76m 4:00 PM EDT 29-May-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
8-KCurrent report pursuant to Section 13 or 15(d)505/27/2020
8-KCurrent report pursuant to Section 13 or 15(d)605/21/2020
10-QGeneral form for quarterly reports under Section 13 or 15(d)7005/06/2020
8-KCurrent report pursuant to Section 13 or 15(d)1105/06/2020
4/A[Amend] Statement of changes in beneficial ownership of securities105/01/2020
4/A[Amend] Statement of changes in beneficial ownership of securities105/01/2020
4/A[Amend] Statement of changes in beneficial ownership of securities105/01/2020
4/A[Amend] Statement of changes in beneficial ownership of securities105/01/2020
8-KCurrent report pursuant to Section 13 or 15(d)305/01/2020
4/A[Amend] Statement of changes in beneficial ownership of securities105/01/2020
DEFA14AAdditional proxy soliciting materials - definitive504/29/2020
DEF 14AOther definitive proxy statements4104/29/2020
8-KCurrent report pursuant to Section 13 or 15(d)304/28/2020
8-KCurrent report pursuant to Section 13 or 15(d)304/21/2020
S-8Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans804/13/2020
<<
First
<
Prev
123456789101112131415